Adaptive Biotechnologies (ADPT) Gross Profit Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) Gross Profit Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 9.56% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 2.50% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 40.07% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 14.32% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 8.47% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 12.14% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 10.79% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 12.13% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 6.29% |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn | 25.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.70% |
| Mar 31, 2026 | 47.10% |
| Dec 31, 2025 | 81.74% |
| Sep 30, 2025 | 154.69% |
| Jun 30, 2025 | 71.24% |
| Mar 31, 2025 | 48.87% |
| Dec 31, 2024 | 12.40% |
| Sep 30, 2024 | 60.28% |
| Jun 30, 2024 | 333.82% |
| Mar 31, 2024 | 25.60% |
| Dec 31, 2023 | -32.22% |
| Sep 30, 2023 | -43.59% |
| Jun 30, 2023 | -133.54% |
| Mar 31, 2023 | -25.41% |
| Dec 31, 2022 | 63.78% |
| Sep 30, 2022 | 30.24% |
| Jun 30, 2022 | 9.73% |
| Mar 31, 2022 | -10.63% |
| Dec 31, 2021 | -1.62% |
| Sep 30, 2021 | 24.85% |